Trastuzumab Deruxtecan 100MG Injection is a HER2-targeted antibody-drug conjugate used for selected HER2-related cancers. The 100MG presentation is supplied as a powder for concentrate for intravenous infusion and must be prepared and administered by qualified healthcare professionals.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter and dropshipping partner supporting eligible international hospitals, oncology centers, pharmaceutical distributors and authorized buyers.
Global Supply of Trastuzumab Deruxtecan 100MG
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply inquiries for eligible buyers in:
Morocco
Kenya
Singapore
Australia
Germany
France
Canada
Saudi Arabia
International availability, import authorization, product registration and prescription requirements depend on the regulations of the destination country.
Uses of Trastuzumab Deruxtecan
Depending on the approved indication, trastuzumab deruxtecan may be used for selected:
HER2-positive breast cancer
HER2-low and HER2-ultralow breast cancer
HER2-mutant non-small cell lung cancer
HER2-positive gastric or gastroesophageal junction cancer
Certain other HER2-positive solid tumors
Appropriate HER2 testing is required for indications based on HER2 expression or mutation status.
Dosage & Administration
The 100MG refers to the vial strength, not necessarily the patient's individual dose.
For several approved indications, the recommended dosage is 5.4 mg/kg by intravenous infusion every 3 weeks. Certain gastric cancer indications use a different weight-based dose. Treatment must be prescribed and administered under specialist medical supervision.
Key Benefits
HER2-targeted oncology treatment
Antibody-drug conjugate technology
Used across multiple approved HER2-related cancer indications
Suitable for selected patients according to their diagnosis and treatment history
Professional international pharmaceutical sourcing support
Side Effects & Safety
Possible adverse effects include nausea, vomiting, fatigue, decreased appetite, low blood-cell counts, anemia and gastrointestinal symptoms.
A major safety concern is interstitial lung disease/pneumonitis, which can be serious or fatal. Patients should immediately report new or worsening cough, shortness of breath, fever or other respiratory symptoms.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International pharmaceutical supply support
Support for hospitals and pharma distributors
Export documentation coordination
Professional order and shipment coordination
Support for eligible international buyers
Service coverage across multiple global markets
For medicines requiring cold-chain or controlled handling, buyers should confirm the required storage and transportation conditions before shipment. The UK product information specifies refrigerated storage at 2°C–8°C for the product.
Fast Delivery & International Dropshipping
Cordium Pharmaceuticals Pvt Ltd can coordinate international pharmaceutical shipments for eligible orders to Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia. Delivery time depends on destination, customs clearance, regulatory documentation, product availability and shipping method.
FAQs
What is Trastuzumab Deruxtecan 100MG Injection?
It is a HER2-targeted antibody-drug conjugate used for selected HER2-related cancers.
Is 100MG the patient's dose?
No. 100MG is the vial presentation. The prescribed dose is calculated according to the indication and patient-specific factors.
Who can order Trastuzumab Deruxtecan?
Eligible hospitals, oncology centers, pharmaceutical distributors and authorized healthcare buyers can inquire, subject to local regulations.
Can it be self-administered?
No. It is an intravenous oncology medicine that requires administration by trained healthcare professionals.
Does Cordium Pharmaceuticals provide international supply?
Cordium Pharmaceuticals Pvt Ltd supports eligible pharmaceutical export inquiries from India for international markets, subject to applicable import and regulatory requirements.
Which countries are targeted for supply?
Supply inquiries can be supported for Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, subject to local regulatory requirements.
Conclusion
Trastuzumab Deruxtecan 100MG Injection is an advanced HER2-targeted oncology medicine for selected cancer indications. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and dropshipping support from India for eligible hospitals, pharma distributors and authorized buyers across Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia.
Medical Disclaimer: This content is for informational and pharmaceutical procurement purposes only. Trastuzumab deruxtecan is a prescription oncology medicine and should be used only under qualified medical supervision.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter and dropshipping partner supporting eligible international hospitals, oncology centers, pharmaceutical distributors and authorized buyers.
Global Supply of Trastuzumab Deruxtecan 100MG
Cordium Pharmaceuticals Pvt Ltd supports pharmaceutical supply inquiries for eligible buyers in:
Morocco
Kenya
Singapore
Australia
Germany
France
Canada
Saudi Arabia
International availability, import authorization, product registration and prescription requirements depend on the regulations of the destination country.
Uses of Trastuzumab Deruxtecan
Depending on the approved indication, trastuzumab deruxtecan may be used for selected:
HER2-positive breast cancer
HER2-low and HER2-ultralow breast cancer
HER2-mutant non-small cell lung cancer
HER2-positive gastric or gastroesophageal junction cancer
Certain other HER2-positive solid tumors
Appropriate HER2 testing is required for indications based on HER2 expression or mutation status.
Dosage & Administration
The 100MG refers to the vial strength, not necessarily the patient's individual dose.
For several approved indications, the recommended dosage is 5.4 mg/kg by intravenous infusion every 3 weeks. Certain gastric cancer indications use a different weight-based dose. Treatment must be prescribed and administered under specialist medical supervision.
Key Benefits
HER2-targeted oncology treatment
Antibody-drug conjugate technology
Used across multiple approved HER2-related cancer indications
Suitable for selected patients according to their diagnosis and treatment history
Professional international pharmaceutical sourcing support
Side Effects & Safety
Possible adverse effects include nausea, vomiting, fatigue, decreased appetite, low blood-cell counts, anemia and gastrointestinal symptoms.
A major safety concern is interstitial lung disease/pneumonitis, which can be serious or fatal. Patients should immediately report new or worsening cough, shortness of breath, fever or other respiratory symptoms.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
India-based pharmaceutical exporter
International pharmaceutical supply support
Support for hospitals and pharma distributors
Export documentation coordination
Professional order and shipment coordination
Support for eligible international buyers
Service coverage across multiple global markets
For medicines requiring cold-chain or controlled handling, buyers should confirm the required storage and transportation conditions before shipment. The UK product information specifies refrigerated storage at 2°C–8°C for the product.
Fast Delivery & International Dropshipping
Cordium Pharmaceuticals Pvt Ltd can coordinate international pharmaceutical shipments for eligible orders to Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia. Delivery time depends on destination, customs clearance, regulatory documentation, product availability and shipping method.
FAQs
What is Trastuzumab Deruxtecan 100MG Injection?
It is a HER2-targeted antibody-drug conjugate used for selected HER2-related cancers.
Is 100MG the patient's dose?
No. 100MG is the vial presentation. The prescribed dose is calculated according to the indication and patient-specific factors.
Who can order Trastuzumab Deruxtecan?
Eligible hospitals, oncology centers, pharmaceutical distributors and authorized healthcare buyers can inquire, subject to local regulations.
Can it be self-administered?
No. It is an intravenous oncology medicine that requires administration by trained healthcare professionals.
Does Cordium Pharmaceuticals provide international supply?
Cordium Pharmaceuticals Pvt Ltd supports eligible pharmaceutical export inquiries from India for international markets, subject to applicable import and regulatory requirements.
Which countries are targeted for supply?
Supply inquiries can be supported for Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, subject to local regulatory requirements.
Conclusion
Trastuzumab Deruxtecan 100MG Injection is an advanced HER2-targeted oncology medicine for selected cancer indications. Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical export and dropshipping support from India for eligible hospitals, pharma distributors and authorized buyers across Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia.
Medical Disclaimer: This content is for informational and pharmaceutical procurement purposes only. Trastuzumab deruxtecan is a prescription oncology medicine and should be used only under qualified medical supervision.
Keywords
